BURLINGTON, N.C.--(BUSINESS WIRE)--Laboratory Corporation of America® Holdings (LabCorp®) (NYSE: LH), an industry leader in prenatal clinical laboratory testing, announced today that it has entered into an agreement with U.K. based Intema Ltd. to license its technology for combining first- and second-trimester Down syndrome screening test results to assess the risk of Down syndrome. Terms of the agreement were not disclosed.
